AVO is focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN. Planning Permission for its Harley Street site has been recently granted, and the first proton beam has successfully been fired from the proton source*. The Metric Capital financing plan has been re-negotiated necessitating (i) a £10m capital increase through a share Subscription at 100p together with an Open Offer, and
02 Nov 2016
Open Offer exceeds expectations
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Open Offer exceeds expectations
Advanced Oncotherapy Plc (AVO:LON) | 1.9 0 0.0% | Mkt Cap: 10.4m
- Published:
02 Nov 2016 -
Author:
Martin Hall -
Pages:
4
AVO is focused on delivering a more affordable, novel proton-based radiotherapy system, based on a technology originally developed and tested at the world renowned CERN. Planning Permission for its Harley Street site has been recently granted, and the first proton beam has successfully been fired from the proton source*. The Metric Capital financing plan has been re-negotiated necessitating (i) a £10m capital increase through a share Subscription at 100p together with an Open Offer, and